Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
      Description

      The study will determine the maximum tolerated dose and thus the recommended phase II dose and schedule of the compound and characterize the safety.

      Conditions
      Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3Squamous Lung Cancer With FGFR1 AmplificationBladder Cancer With FGFR3 Mutation or FusionAdvanced Solid Tumors With FGFR1 AmplicationAdvanced Solid Tumors With FGFR2 AmplicationAdvanced Solid Tumors With FGFR3 Mutation
      Talk to us